(Q46617487)

23 December 2017

title

Omega-3/omega-6 fatty acids for attention deficit hyperactivity disorder: a randomized placebo-controlled trial in children and adolescents (English)

1 reference

23 December 2017

attention deficit hyperactivity disorder

1 reference

1 reference

1 reference

1 reference

based on heuristic

inferred from title

placebo-controlled trial

1 reference

5

Christopher Gillberg

1 reference

23 December 2017

Mats Johnson

1

1 reference

23 December 2017

Sven Ostlund

series ordinal

2

1 reference

23 December 2017

Gunnar Fransson

series ordinal

3

1 reference

23 December 2017

Björn Kadesjö

series ordinal

4

1 reference

23 December 2017

publication date

30 April 2008

1 reference

23 December 2017

Journal of Attention Disorders

published in

1 reference

23 December 2017

volume

12

1 reference

23 December 2017

issue

5

1 reference

23 December 2017

page(s)

394-401

1 reference

23 December 2017

Function of dietary polyunsaturated fatty acids in the nervous system

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1087054708316261

Effect of docosahexaenoic acid-containing food administration on symptoms of attention-deficit/hyperactivity disorder - a placebo-controlled double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054708316261

Developmental coordination disorder in Swedish 7-year-old children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054708316261

The comorbidity of ADHD in the general population of Swedish school-age children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054708316261

Atomoxetine and methylphenidate treatment in children with ADHD: a prospective, randomized, open-label trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054708316261

Relapse prevention in pediatric patients with ADHD treated with atomoxetine: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054708316261

Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054708316261

A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054708316261

The Oxford-Durham study: a randomized, controlled trial of dietary supplementation with fatty acids in children with developmental coordination disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054708316261

A randomized double-blind, placebo-controlled study of the effects of supplementation with highly unsaturated fatty acids on ADHD-related symptoms in children with specific learning difficulties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054708316261

Effect of supplementation with polyunsaturated fatty acids and micronutrients on learning and behavior problems associated with child ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054708316261

EFA supplementation in children with inattention, hyperactivity, and other disruptive behaviors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054708316261

A randomized, double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054708316261

21 January 2018

Identifiers

DOI

10.1177/1087054708316261

1 reference

23 December 2017

PubMed ID

18448859

1 reference

23 December 2017